What is Shandong Weigao Group Medical Polymer Co FCF Margin %?
Shandong Weigao Group Medical Polymer CoSHWGY 70 FCF Margin % is 24.75% as of Dec. 2025, which is 81% above its 10-year median of 13.71. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.17 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Shandong Weigao Group Medical Polymer Co ranks better than 89.2% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co FCF Margin % Chart
Shandong Weigao Group Medical Polymer Co Annual Data
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co (SHWGY) has a FCF Margin % of 24.75% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. This is 81% above median its historical median of 13.71. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #88 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 10.8%.
Is Shandong Weigao Group Medical Polymer Co's FCF Margin % too high?
Shandong Weigao Group Medical Polymer Co's current FCF Margin % of 24.75% is 81% above median its 10-year median of 13.71. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #88 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #88 out of 815 companies for FCF Margin %. This places Shandong Weigao Group Medical Polymer Co in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current FCF Margin % is 24.75%, which is 81% above median its own 10-year median of 13.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.17, compared to a current price of $1.58 — trading 50.2% below its estimated fair value. The current FCF Margin % is 24.75%, which is 81% above median its 10-year median of 13.71. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current FCF Margin % is 24.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $1.58 is trading 50.2% below its estimated GF Value™ of $3.17.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGY:
FCF Margin %: 24.75% (81% above median its 10-year median of 13.71)
GF Value™: $3.17 vs. price of $1.58 (50.2% below fair value)
No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score
Get the complete analysis for SHWGY
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGY has been successfully added to your 
